MC
GOSS icon

Moors & Cabot’s Gossamer Bio GOSS Stock Holding History

Moors & Cabot’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,000
Closed -$12.1K – 919
2025
Q1 		$12.1K Buy
11,000
+1,000
+10% +$1.16K ﹤0.01% 864
2024
Q4 		$9.05K Hold
10,000
– – ﹤0.01% 880
2024
Q3 		$9.86K Hold
10,000
– – ﹤0.01% 873
2024
Q2 		$9.01K Buy
+10,000
New +$7.48K ﹤0.01% 843

Other funds holding GOSS

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Moors & Cabot's GOSS Position: Q2 2025 in Review

Moors & Cabot sold out of Gossamer Bio (GOSS) in Q2 2025, closing a stake of 11,000 shares — an estimated $12.1K sold.

Moors & Cabot first reported a position in GOSS in Q2 2024 and held it in 4 quarters. The position peaked at $12.1K in Q1 2025. 123 funds tracked by Wall St. Rank hold GOSS as of Q2 2025.

  • Moors & Cabot reported no remaining Gossamer Bio position as of Q2 2025 after selling out during the quarter.
  • Moors & Cabot sold 11,000 Gossamer Bio shares in Q2 2025, an estimated $12.1K.
  • Moors & Cabot first reported a position in Gossamer Bio in Q2 2024 and held it in 4 quarters.
  • Moors & Cabot's Gossamer Bio position peaked at $12.1K in Q1 2025.
  • 123 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2025.

Based on Moors & Cabot's 13F filing for Q2 2025, filed 6 Aug 2025.